Emergence of KRAS-mutation in liver metastases after an anti-EGFR treatment in patient with colorectal cancer: Are we aware of the therapeutic impact of intratumor heterogeneity?

Baretti, M

Emergence of KRAS-mutation in liver metastases after an anti-EGFR treatment in patient with colorectal cancer: Are we aware of the therapeutic impact of intratumor heterogeneity? [electronic resource] - Cancer biology & therapy 08 2018 - 659-663 p. digital

Publication Type: Case Reports; Journal Article

1555-8576

10.1080/15384047.2018.1450117 doi


Aged
Antineoplastic Agents--pharmacology
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Biomarkers
Colorectal Neoplasms--drug therapy
ErbB Receptors--antagonists & inhibitors
Female
Humans
Immunohistochemistry
Liver Neoplasms--diagnosis
Molecular Targeted Therapy
Mutation
Proto-Oncogene Proteins p21(ras)--genetics
Tomography, X-Ray Computed
Treatment Outcome